Patent ID: 8022071
Filing Date: 2011-09-20
Classification: A61P,C07D

Abstract:
1. A method of inhibiting phosphorylation of PDGF receptor in a patient comprising administering a compound of the formula: wherein R is a member selected from the group consisting of: (a) phenyl, which is independently substituted with 0-2 R (b) naphthyl, which is independently substituted with 0-2 R (c) a monocyclic or fused bicyclic heterocyclic ring system having from 5 to 10 ring atoms, wherein 1-4 ring atoms of the ring system are selected from the group consisting of N, O and S, and wherein the ring system may be substituted with 0-2 R R R m is an integer of 0-2; R R n is 2 or 3; R and all pharmaceutically acceptable salts thereof to the patient.